A study suggests that two diabetes drugs – Januvia and Byetta – may raise the risk of pancreatitis and pancreatic cancer, according to a story in USA Today. The study found that Byetta may also carry an increased risk of thyroid cancer.
Lopez McHugh is reviewing cases involving pancreatic cancer with Januvia and Byetta. If you or a loved one received this diagnosis while on either of these drugs, call or ...
continue reading...An item on the blog Pharmalot examines an e-mail suggesting that drugmaker Bristol-Myers Squibb plans to get physicians to lobby state Medicaid programs on the company’s behalf.
According to Pharmalot, the e-mail was sent to the district business manager team with the goal of getting Medicaid programs in Pennsylvania, Delaware and Maryland to place the Onglyza diabetes drug on the state formularies.
Although the blog doesn’t say that the company was doing anything illegal, it does point out that the region business ...
continue reading...An Irish newspaper, the Evening Herald, reports that diabetics in Europe have been warned about a drug used to lower blood sugar, which has been linked to severe side-effects.
According to the report, patients have suffered “serious hypersensitivity reactions” including anaphylactic shock and acute pancreatitis.
Both the Irish Medicines Board and the European Medicines Agency issued warnings about the drug saxagliptin, which has the brand name Onglyza, prescribed for patients with Type 2 diabetes as part of a diet and exercise program ...
continue reading...
